HR 8358 United States House · 119th Congress

Breast Cancer Research Stamp Reauthorization Act of 2026

This bill, the Breast Cancer Research Stamp Reauthorization Act of 2026, extends the period during which a special postage stamp can be sold to raise funds for breast cancer research. It amends existing law to change the program's expiration date. Specifically, the bill allows the U.S. Postal Service to continue selling the Breast Cancer Research Stamp until 2037, extending its current authorization which was set to expire in 2027. This change aims to continue providing a dedicated funding source for breast cancer research through stamp sales, affecting stamp purchasers and breast cancer research institutions.

Bill status in committee 1 of 4 stages cleared

Introduction

Apr 2026

Committee Review

Floor Vote

President

Introduced Apr 16, 2026 Last action Apr 16, 2026

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 16, 2026

Committee

Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Apr 16, 2026

Introduced

Introduced in House

lower

1 primary · 11 co-sponsors